AnalystBook Research · Company Intelligence

FS KKR Capital Corp

FSKNYSE

Built from FS KKR Capital Corp's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Net income decreased 98.1% to $11.0M, while Operating cash flow decreased 68.9% to $592.0M.

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue N/AOK
  • ProfitabilityNet income $11.0MOK
  • Cash generationFree cash flow N/ANote
  • AccountingNo applicable forensic screenNote
  • Insiders7 buys; 0 sells in 365 daysOK
  • Capitaldividends paid were $784.0M; share repurchases were $0Note

Business

FS KKR Capital Corp: Our portfolio is comprised primarily of investments in senior secured debt, which includes first and second lien secured loans and senior secured bonds, of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies.

Leadership changes

From FS KKR Capital Corp's own filings, the day they're filed.

  • Brian Gerson · President · departureeff. 2025-06-28
  • Daniel Pietrzak · Chief Investment Officer · appointmenteff. 2025-02-03

Latest filings

  • 8-K · Company announcement2026-08-20
  • 8-K · Company announcement2026-08-13
  • 8-K · Company announcement2026-08-06
  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-07-09
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about FS KKR Capital Corp, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.